论文信息 - Daratumumab Plus Lenalidomide and Dexamethasone (D-Rd) Versus Lenalidomide and Dexamethasone (Rd) in Patients with Newly Diagnosed Multiple Myeloma (NDMM) Ineligible for Transplant: Updated Analysis of Maia - 字舞流文

Daratumumab Plus Lenalidomide and Dexamethasone (D-Rd) Versus Lenalidomide and Dexamethasone (Rd) in Patients with Newly Diagnosed Multiple Myeloma (NDMM) Ineligible for Transplant: Updated Analysis of Maia

H. Goldschmidt | Shaji K. Kumar | T. Plesner | R. Orlowski | H. Nahi | S. Basu | C. Touzeau | T. Facon | S. Usmani | M. O'Dwyer | A. Perrot | C. Hulin | K. Weisel | N. Bahlis | J. Ukropec | Jianping Wang | C. Uhlar | Maria I Krevvata | C. Venner | H. Quach | R. Kobos | H. Pei | M. Krevvata | R. V. Rampelbergh